AI and ML-based algorithms will provide impetus for Next-Gen diagnostics: Anand K, CEO, SRL Diagnostics
Testing for COVID-19 has seen a significant drop from being about 30 percent of SRLâs revenue in January to almost 7 percent in March. The CEO of SRL Diagnostics says that going forward about to 3-4 percent of their overall testing will be COVID-related, and the remaining, non-Covidfrom Moneycontrol Business News https://ift.tt/TflR0Kb
Comments
Post a Comment